Harada S - Search Results

1

Inhibition of human immunodeficiency virus reverse transcriptase by synadenol triphosphate and its E-isomer.

Wang R, Harada S, Mitsuya H, Zemlicka J. Wang R, et al. Among authors: harada s. J Med Chem. 2003 Oct 23;46(22):4799-802. doi: 10.1021/jm030048y. J Med Chem. 2003. PMID: 14561099

2

Emergence of human immunodeficiency virus type 1 variants containing the Q151M complex in children receiving long-term antiretroviral chemotherapy.

Harada S, Hazra R, Tamiya S, Zeichner SL, Mitsuya H. Harada S, et al. Antiviral Res. 2007 Aug;75(2):159-66. doi: 10.1016/j.antiviral.2007.02.004. Epub 2007 Mar 21. Antiviral Res. 2007. PMID: 17418430 Clinical Trial.

3

Novel patterns of nevirapine resistance-associated mutations of human immunodeficiency virus type 1 in treatment-naïve patients.

Hachiya A, Gatanaga H, Kodama E, Ikeuchi M, Matsuoka M, Harada S, Mitsuya H, Kimura S, Oka S. Hachiya A, et al. Among authors: harada s. Virology. 2004 Oct 1;327(2):215-24. doi: 10.1016/j.virol.2004.07.001. Virology. 2004. PMID: 15351209 Free article.

4

Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants.

Matsumi S, Kosalaraksa P, Tsang H, Kavlick MF, Harada S, Mitsuya H. Matsumi S, et al. Among authors: harada s. AIDS. 2003 May 23;17(8):1127-37. doi: 10.1097/00002030-200305230-00003. AIDS. 2003. PMID: 12819513

5

Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication.

Miyakawa T, Obaru K, Maeda K, Harada S, Mitsuya H. Miyakawa T, et al. Among authors: harada s. J Biol Chem. 2002 Feb 15;277(7):4649-55. doi: 10.1074/jbc.M109198200. Epub 2001 Dec 4. J Biol Chem. 2002. PMID: 11734558 Free article.

6

Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.

Davis DA, Brown CA, Singer KE, Wang V, Kaufman J, Stahl SJ, Wingfield P, Maeda K, Harada S, Yoshimura K, Kosalaraksa P, Mitsuya H, Yarchoan R. Davis DA, et al. Among authors: harada s. Antiviral Res. 2006 Nov;72(2):89-99. doi: 10.1016/j.antiviral.2006.03.015. Epub 2006 Apr 21. Antiviral Res. 2006. PMID: 16687179

7

Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s.

Nakata H, Maeda K, Das D, Chang SB, Matsuda K, Rao KV, Harada S, Yoshimura K, Ghosh AK, Mitsuya H. Nakata H, et al. Among authors: harada s. Sci Rep. 2019 Mar 18;9(1):4828. doi: 10.1038/s41598-019-41080-w. Sci Rep. 2019. PMID: 30886166 Free PMC article.

8

Design, synthesis, and bio-evaluation of novel triterpenoid derivatives as anti-HIV-1 compounds.

Takeuchi R, Ogihara K, Fujimoto J, Sato K, Mase N, Yoshimura K, Harada S, Narumi T. Takeuchi R, et al. Among authors: harada s. Bioorg Med Chem Lett. 2022 Aug 1;69:128768. doi: 10.1016/j.bmcl.2022.128768. Epub 2022 May 2. Bioorg Med Chem Lett. 2022. PMID: 35513221

9

CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.

Narumi T, Arai H, Yoshimura K, Harada S, Hirota Y, Ohashi N, Hashimoto C, Nomura W, Matsushita S, Tamamura H. Narumi T, et al. Among authors: harada s. Bioorg Med Chem. 2013 May 1;21(9):2518-26. doi: 10.1016/j.bmc.2013.02.041. Epub 2013 Mar 7. Bioorg Med Chem. 2013. PMID: 23535561

10

CD4 mimics targeting the mechanism of HIV entry.

Yamada Y, Ochiai C, Yoshimura K, Tanaka T, Ohashi N, Narumi T, Nomura W, Harada S, Matsushita S, Tamamura H. Yamada Y, et al. Among authors: harada s. Bioorg Med Chem Lett. 2010 Jan 1;20(1):354-8. doi: 10.1016/j.bmcl.2009.10.098. Epub 2009 Nov 4. Bioorg Med Chem Lett. 2010. PMID: 19926478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,137 results

Search Page

Filters